MRPS31 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.758200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.695820E-01
Normal-vs-Stage2
6.518300E-02
Normal-vs-Stage3
1.730370E-01
Normal-vs-Stage4
1.870110E-02
Stage1-vs-Stage2
3.046000E-01
Stage1-vs-Stage3
2.409400E-01
Stage1-vs-Stage4
2.243200E-01
Stage2-vs-Stage3
3.766600E-01
Stage2-vs-Stage4
9.729000E-01
Stage3-vs-Stage4
6.198400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.962400E-02
Normal-vs-AfricanAmerican
5.108100E-02
Normal-vs-Asian
2.722000E-01
Caucasian-vs-AfricanAmerican
2.937400E-03
Caucasian-vs-Asian
3.348800E-01
AfricanAmerican-vs-Asian
7.405600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.663900E-02
Normal-vs-Female
9.361900E-02
Male-vs-Female
5.393400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.552380E-01
Normal-vs-Age(41-60Yrs)
7.603500E-02
Normal-vs-Age(61-80Yrs)
6.646300E-02
Normal-vs-Age(81-100Yrs)
8.072400E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.511600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.997800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.004200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.563900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.867600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.454000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.528200E-02
Normal-vs-Daily Drinker
6.249700E-02
Normal-vs-Weekly Drinker
1.216370E-02
Normal-vs-Occasional Drinker
9.887500E-02
Normal-vs-Social Drinker
1.615610E-01
Non Drinker-vs-Daily Drinker
6.596000E-01
Non Drinker-vs-Weekly Drinker
9.772400E-01
Non Drinker-vs-Occasional Drinker
3.018100E-02
Non Drinker-vs-Social Drinker
1.299150E-01
Daily Drinker-vs-Weekly Drinker
7.205000E-01
Daily Drinker-vs-Occasional Drinker
1.175750E-01
Daily Drinker-vs-Social Drinker
3.112800E-01
Weekly Drinker-vs-Occasional Drinker
3.410500E-02
Weekly Drinker-vs-Social Drinker
1.646390E-01
Occasional Drinker-vs-Social Drinker
7.030200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.002300E-02
Normal-vs-Grade 2
4.996400E-01
Normal-vs-Grade 3
5.028800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.062000E-01
Grade 1-vs-Grade 3
7.741200E-01
Grade 1-vs-Grade 4
8.002300E-02
Grade 2-vs-Grade 3
9.378200E-01
Grade 2-vs-Grade 4
4.996400E-01
Grade 3-vs-Grade 4
5.028800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.190500E-02
Normal-vs-NonDiabetic
7.268300E-02
Diabetic-vs-NonDiabetic
8.280500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.382300E-02
Normal-vs-NoPancreatitis
5.821800E-02
Pancreatitis-vs-NoPancreatitis
7.162000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.520400E-02
Normal-vs-N1
6.886100E-02
N0-vs-N1
2.917200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.262590E-01
Normal-vs-TP53-NonMutant
1.704560E-01
TP53-Mutant-vs-TP53-NonMutant
8.358200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
